1. Home
  2. STBA vs RAPP Comparison

STBA vs RAPP Comparison

Compare STBA & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$43.80

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$34.17

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STBA
RAPP
Founded
1902
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
STBA
RAPP
Price
$43.80
$34.17
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$43.00
$48.50
AVG Volume (30 Days)
197.9K
256.4K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.23%
N/A
EPS Growth
2.35
24.34
EPS
3.49
N/A
Revenue
N/A
N/A
Revenue This Year
$10.20
N/A
Revenue Next Year
$4.14
N/A
P/E Ratio
$12.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.45
$7.73
52 Week High
$44.91
$42.27

Technical Indicators

Market Signals
Indicator
STBA
RAPP
Relative Strength Index (RSI) 64.07 66.52
Support Level $42.08 $25.48
Resistance Level $44.86 $42.27
Average True Range (ATR) 0.89 1.92
MACD 0.40 0.56
Stochastic Oscillator 79.22 88.40

Price Performance

Historical Comparison
STBA
RAPP

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: